Terms: = Cervical cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
3 results:
1. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation analysis of Poor prognosis and Immunotherapy of lncRNAs Related with m
Gu R; Liu M; Lin P; Feng TY; Yuan H; Ou DQ; Li SQ; Li Q; Zhao G; Zhang J; Li K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):626-636. PubMed ID: 35871733
[TBL] [Abstract] [Full Text] [Related]
3. Increased nuclear expression of growth hormone receptor in uterine cervical neoplasms of women under 40 years old.
Dehari R; Nakamura Y; Okamoto N; Nakayama H
Tohoku J Exp Med; 2008 Oct; 216(2):165-72. PubMed ID: 18832799
[TBL] [Abstract] [Full Text] [Related]
